[1]
I. Vacheva, “THE ANTI-INTERLEUKIN-31 ANTIBODY LOKIVETMAB AS A NEW ADDITIONAL OPTION FOR CANINE ATOPIC DERMATITIS MANAGEMENT”, Tradit. Mod. Vet. Med., vol. 11, no. 1, pp. 49–54, Apr. 2026.